SCHEMBL25105331

SCHEMBL25105331

CC(C)(C)NC1CB(C#N)CC1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25105334 0.64 — —
SCHEMBL25105320 0.63 — —
SCHEMBL21166020 0.59 — —
SCHEMBL25105928 0.57 SSTR4 (0.31) —
SCHEMBL25105330 0.57 SSTR4 (0.31) —
SCHEMBL14176519 0.57 — —
SCHEMBL19367684 0.53 SIGMAR1 (0.30) —
SCHEMBL18931235 0.53 — —
SCHEMBL26793854 0.53 — —
SCHEMBL20063377 0.52 SIGMAR1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023034836-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC. (US) 2023-03-09 — — WO disclosed
Send feedback